| Meagan Hilburn, FNP-C | |
|
1010 Highway 17 N, North Myrtle Beach, SC 29582-2806 | |
| (843) 249-1451 | |
| Not Available |
| Full Name | Meagan Hilburn |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1010 Highway 17 N, North Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336500271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 20083 (South Carolina) | Primary |
| Entity Name | Ph Health Care Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427475292 PECOS PAC ID: 2163683012 Enrollment ID: O20140722002387 |
News Archive
Now, a new study by researchers at AncestryDNA, a company that provides DNA testing services that use modern autosomal testing technology, shows that some people are more susceptible to COVID-19 infection, and they may experience more severe outcomes, including males, the elderly, and those with comorbidities.
Men experience a higher burden of disease and lower life expectancy than women, but policies focusing on the health needs of men are notably absent from the strategies of global health organisations, according to a Viewpoint article in this week's Lancet.
Amgen Inc., the world's largest biotechnology company, and Tularik Inc., a pioneer in drug discovery related to cell signaling and the control of gene expression, today jointly announced that they have signed a definitive merger agreement whereby Tularik will become a wholly-owned subsidiary of Amgen in a stock for stock transaction.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5%. Watson's Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% is a generic version of Alcon, Inc.'s Vigamox®, an antibiotic solution that is indicated for the treatment of bacterial conjunctivitis.
The rate of myocardium glucose utilisation in the right ventricle correlates with its function and could be used to monitor treatment effects in patients with pulmonary arterial hypertension, findings indicate.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meagan Hilburn, FNP-C 1010 Highway 17 N, North Myrtle Beach, SC 29582-2806 Ph: (843) 249-1451 | Meagan Hilburn, FNP-C 1010 Highway 17 N, North Myrtle Beach, SC 29582-2806 Ph: (843) 249-1451 |
News Archive
Now, a new study by researchers at AncestryDNA, a company that provides DNA testing services that use modern autosomal testing technology, shows that some people are more susceptible to COVID-19 infection, and they may experience more severe outcomes, including males, the elderly, and those with comorbidities.
Men experience a higher burden of disease and lower life expectancy than women, but policies focusing on the health needs of men are notably absent from the strategies of global health organisations, according to a Viewpoint article in this week's Lancet.
Amgen Inc., the world's largest biotechnology company, and Tularik Inc., a pioneer in drug discovery related to cell signaling and the control of gene expression, today jointly announced that they have signed a definitive merger agreement whereby Tularik will become a wholly-owned subsidiary of Amgen in a stock for stock transaction.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5%. Watson's Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% is a generic version of Alcon, Inc.'s Vigamox®, an antibiotic solution that is indicated for the treatment of bacterial conjunctivitis.
The rate of myocardium glucose utilisation in the right ventricle correlates with its function and could be used to monitor treatment effects in patients with pulmonary arterial hypertension, findings indicate.
› Verified 6 days ago
Roman Koryakin, FNP, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3816 Highway 17 S, North Myrtle Beach, SC 29582 Phone: 843-272-1411 | |
Sandra Lee Payne, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 843-249-1451 | |
Ms. Stacey Lynn Shaw, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2423 Highway 17 S, North Myrtle Beach, SC 29582 Phone: 843-919-0700 Fax: 843-919-0727 | |
Joann Kay Williams, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 866-389-2727 | |
Mrs. Tisha Michelle Brown, APRN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 866-389-2727 | |
Tracey Michelle Lewis, APRN, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2021 N Myrtle Point Blvd Ste 102, North Myrtle Beach, SC 29582 Phone: 843-366-3060 Fax: 843-366-3069 | |
Jessica Smith, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1010 Highway 17 N, North Myrtle Beach, SC 29582 Phone: 843-685-0180 |